Johnson & Johnson (JNJ) Short-Term Debt repayments (2009 - 2026)
Johnson & Johnson recorded quarterly Short-Term Debt repayments of $3.2 billion in Q1 2026, up 78.46% quarter-over-quarter from $1.8 billion in Q4 2025, and up 52.03% year-over-year from $2.1 billion in Q1 2025.
Johnson & Johnson's Short-Term Debt repayments history runs 18 years deep, the most recent figure standing at $3.2 billion for Q1 2026.
- In Q1 2026, Short-Term Debt repayments rose 52.03% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $13.4 billion (up 25.62% YoY), while the FY2025 annual figure was $12.3 billion, up 30.3% from the prior year.
- Short-Term Debt repayments came in at $3.2 billion for Q1 2026 at Johnson & Johnson, up from $1.8 billion in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of $8.2 billion in Q3 2023 to a low of $856.0 million in Q2 2022.
- A 5-year average of $3.6 billion and a median of $3.0 billion in 2024 frame the typical range for Short-Term Debt repayments.
- Across the five-year window, Short-Term Debt repayments jumped 529.44% in 2023 and slumped 83.48% in 2024, its largest moves.
- Johnson & Johnson's Short-Term Debt repayments stood at $856.0 million in 2022, then jumped by 55.14% to $1.3 billion in 2023, then slipped by 16.49% to $1.1 billion in 2024, then surged by 62.85% to $1.8 billion in 2025, then soared by 78.46% to $3.2 billion in 2026.
- According to Business Quant data, Short-Term Debt repayments over the past three periods registered $3.2 billion, $1.8 billion, and $5.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | -73.00 Mn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 3.22 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 3.22 Bn |
| Mar 29, 2026 | 3.22 Bn |
| Dec 28, 2025 | 1.81 Bn |
| Dec 28, 2025 | 1.81 Bn |
| Sep 28, 2025 | 5.47 Bn |
| Sep 28, 2025 | 5.47 Bn |
| Jun 29, 2025 | 2.94 Bn |
| Jun 29, 2025 | 2.94 Bn |
| Mar 30, 2025 | 2.12 Bn |
| Mar 30, 2025 | 2.12 Bn |
| Dec 29, 2024 | 1.11 Bn |
| Dec 29, 2024 | 1.11 Bn |
| Sep 29, 2024 | 4.44 Bn |
| Sep 29, 2024 | 4.44 Bn |
| Jun 30, 2024 | 3.03 Bn |
| Jun 30, 2024 | 3.03 Bn |
| Mar 31, 2024 | 890.00 Mn |
| Mar 31, 2024 | 890.00 Mn |
| Dec 31, 2023 | 1.33 Bn |
| Dec 31, 2023 | 1.33 Bn |
| Oct 1, 2023 | 8.03 Bn |
| Oct 1, 2023 | 8.03 Bn |
| Jul 2, 2023 | 8.22 Bn |
| Jul 2, 2023 | 8.22 Bn |
| Apr 2, 2023 | 5.39 Bn |
| Apr 2, 2023 | 5.39 Bn |
| Jan 1, 2023 | 5.73 Bn |
| Jan 1, 2023 | 5.73 Bn |
| Apr 3, 2022 | 856.00 Mn |
| Apr 3, 2022 | 856.00 Mn |
| Oct 3, 2021 | 132.00 Mn |
| Oct 3, 2021 | 132.00 Mn |
| Jul 4, 2021 | 214.00 Mn |
| Jul 4, 2021 | 214.00 Mn |
| Apr 4, 2021 | 475.00 Mn |
| Apr 4, 2021 | 475.00 Mn |
| Jan 3, 2021 | 2.35 Bn |
| Jan 3, 2021 | 2.35 Bn |
| Sep 27, 2020 | 293.00 Mn |
| Sep 27, 2020 | 293.00 Mn |
| Jun 28, 2020 | -1.00 Mn |
| Jun 28, 2020 | -1.00 Mn |
| Mar 29, 2020 | 18.00 Mn |
| Mar 29, 2020 | 18.00 Mn |
| Dec 29, 2019 | 13.00 Mn |
| Dec 29, 2019 | 13.00 Mn |
| Sep 29, 2019 | 75.00 Mn |
| Sep 29, 2019 | 75.00 Mn |
| Jun 30, 2019 | -4.00 Mn |
| Jun 30, 2019 | -4.00 Mn |
| Mar 31, 2019 | 16.00 Mn |
| Mar 31, 2019 | 16.00 Mn |
| Dec 30, 2018 | 114.00 Mn |
| Dec 30, 2018 | 114.00 Mn |
| Sep 30, 2018 | -68.00 Mn |
| Sep 30, 2018 | -68.00 Mn |
| Jul 1, 2018 | -51.00 Mn |
| Jul 1, 2018 | -51.00 Mn |
| Apr 1, 2018 | 2.48 Bn |
| Apr 1, 2018 | 2.48 Bn |
| Dec 31, 2017 | 394.00 Mn |
| Dec 31, 2017 | 394.00 Mn |
| Oct 1, 2017 | 756.00 Mn |
| Oct 1, 2017 | 756.00 Mn |
| Jul 2, 2017 | -15.00 Mn |
| Jul 2, 2017 | -15.00 Mn |
| Apr 2, 2017 | 195.00 Mn |
| Apr 2, 2017 | 195.00 Mn |
| Jan 1, 2017 | 1.09 Bn |
| Jan 1, 2017 | 1.09 Bn |
| Apr 3, 2016 | 4.17 Bn |
| Apr 3, 2016 | 4.17 Bn |
| Sep 27, 2015 | 585.00 Mn |
| Sep 27, 2015 | 585.00 Mn |
| Jun 28, 2015 | 152.00 Mn |
| Jun 28, 2015 | 152.00 Mn |
| Mar 29, 2015 | 193.00 Mn |
| Mar 29, 2015 | 193.00 Mn |
| Dec 28, 2014 | -446.00 Mn |
| Dec 28, 2014 | -446.00 Mn |
| Sep 28, 2014 | 647.00 Mn |
| Sep 28, 2014 | 647.00 Mn |
| Jun 29, 2014 | -209.00 Mn |
| Jun 29, 2014 | -209.00 Mn |
| Mar 30, 2014 | 1.28 Bn |
| Mar 30, 2014 | 1.28 Bn |
| Dec 29, 2013 | -19.00 Mn |
| Dec 29, 2013 | -19.00 Mn |
| Sep 29, 2013 | 142.00 Mn |
| Sep 29, 2013 | 142.00 Mn |
| Jun 30, 2013 | 570.00 Mn |
| Jun 30, 2013 | 570.00 Mn |
| Mar 31, 2013 | 704.00 Mn |
| Mar 31, 2013 | 704.00 Mn |
| Dec 30, 2012 | 395.00 Mn |
| Dec 30, 2012 | 395.00 Mn |
| Sep 30, 2012 | 1.00 Bn |
| Sep 30, 2012 | 1.00 Bn |
| Jul 1, 2012 | 2.99 Bn |
| Jul 1, 2012 | 2.99 Bn |
| Apr 1, 2012 | 1.79 Bn |
| Apr 1, 2012 | 1.79 Bn |
| Jan 1, 2012 | 5.81 Bn |
| Jan 1, 2012 | 5.81 Bn |
| Apr 3, 2011 | 2.74 Bn |
| Apr 3, 2011 | 2.74 Bn |
| Oct 3, 2010 | 1.79 Bn |
| Oct 3, 2010 | 1.79 Bn |
| Jul 4, 2010 | 555.00 Mn |
| Jul 4, 2010 | 555.00 Mn |
| Apr 4, 2010 | 3.04 Bn |
| Apr 4, 2010 | 3.04 Bn |
| Jan 3, 2010 | 2.78 Bn |
| Jan 3, 2010 | 2.78 Bn |
| Sep 27, 2009 | 2.68 Bn |
| Sep 27, 2009 | 2.68 Bn |
| Jun 28, 2009 | 274.00 Mn |
| Jun 28, 2009 | 274.00 Mn |
| Mar 29, 2009 | 1.06 Bn |
| Mar 29, 2009 | 1.06 Bn |